Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 30

1.

Statin drugs and risk of advanced prostate cancer.

Platz EA, Leitzmann MF, Visvanathan K, Rimm EB, Stampfer MJ, Willett WC, Giovannucci E.

J Natl Cancer Inst. 2006 Dec 20;98(24):1819-25.

PMID:
17179483
2.

Review of recent evidence in support of a role for statins in the prevention of prostate cancer.

Hamilton RJ, Freedland SJ.

Curr Opin Urol. 2008 May;18(3):333-9. doi: 10.1097/MOU.0b013e3282f9b3cc. Review.

PMID:
18382245
3.

Association between statin usage and prostate cancer prevention: a refined meta-analysis based on literature from the years 2005-2010.

Zhang Y, Zang T.

Urol Int. 2013;90(3):259-62. doi: 10.1159/000341977. Epub 2012 Oct 9. Review.

PMID:
23052323
4.

Fish consumption and prostate cancer risk: a review and meta-analysis.

Szymanski KM, Wheeler DC, Mucci LA.

Am J Clin Nutr. 2010 Nov;92(5):1223-33. doi: 10.3945/ajcn.2010.29530. Epub 2010 Sep 15. Review.

5.

Smoking and aggressive prostate cancer: a review of the epidemiologic evidence.

Zu K, Giovannucci E.

Cancer Causes Control. 2009 Dec;20(10):1799-810. doi: 10.1007/s10552-009-9387-y. Review.

PMID:
19562492
6.

Changing demography of prostate cancer in Asia.

Sim HG, Cheng CW.

Eur J Cancer. 2005 Apr;41(6):834-45. Review.

PMID:
15808953
7.

Statins and prostate cancer: molecular and clinical aspects.

Papadopoulos G, Delakas D, Nakopoulou L, Kassimatis T.

Eur J Cancer. 2011 Apr;47(6):819-30. doi: 10.1016/j.ejca.2011.01.005. Epub 2011 Feb 25. Review.

PMID:
21354784
8.

Energy imbalance and prostate cancer.

Platz EA.

J Nutr. 2002 Nov;132(11 Suppl):3471S-3481S. Review.

9.

Prostate cancer and coronary heart disease: correlation or coincidence?

Moyad MA, Sonnleithner M.

Urol Clin North Am. 2004 May;31(2):207-12. Review.

PMID:
15123400
10.

Does physical activity reduce the risk of prostate cancer? A systematic review and meta-analysis.

Liu Y, Hu F, Li D, Wang F, Zhu L, Chen W, Ge J, An R, Zhao Y.

Eur Urol. 2011 Nov;60(5):1029-44. doi: 10.1016/j.eururo.2011.07.007. Epub 2011 Jul 19. Review.

PMID:
21802197
11.

Proportion and risk indicators of nonadherence to statin therapy: a meta-analysis.

Lemstra M, Blackburn D, Crawley A, Fung R.

Can J Cardiol. 2012 Sep-Oct;28(5):574-80. doi: 10.1016/j.cjca.2012.05.007. Epub 2012 Aug 10. Review.

PMID:
22884278
12.
13.

Association between statins and clinical outcomes among men with prostate cancer: a systematic review and meta-analysis.

Raval AD, Thakker D, Negi H, Vyas A, Kaur H, Salkini MW.

Prostate Cancer Prostatic Dis. 2016 Jun;19(2):151-62. doi: 10.1038/pcan.2015.58. Epub 2016 Jan 19. Review. Erratum in: Prostate Cancer Prostatic Dis. 2016 Jun;19(2):222. Kaur, H [added].

PMID:
26782711
14.

Exercise and prostate cancer.

Torti DC, Matheson GO.

Sports Med. 2004;34(6):363-9. Review.

PMID:
15157121
15.

Changing trends of prostate cancer in Asia.

Pu YS, Chiang HS, Lin CC, Huang CY, Huang KH, Chen J.

Aging Male. 2004 Jun;7(2):120-32. Review.

PMID:
15672937
16.

Isoflavones and the prevention and treatment of prostate disease: is there a role?

Gaynor ML.

Cleve Clin J Med. 2003 Mar;70(3):203-4, 206, 208-9 passim. Review.

PMID:
12678210
17.

Epidemiology of prostate cancer.

Dijkman GA, Debruyne FM.

Eur Urol. 1996;30(3):281-95. Review.

PMID:
8931959
18.

Prostate cancer and schizophrenia.

Torrey EF.

Urology. 2006 Dec;68(6):1280-3. Epub 2006 Dec 4. Review.

PMID:
17141844
19.

Statin use and mortality in cancer patients: Systematic review and meta-analysis of observational studies.

Zhong S, Zhang X, Chen L, Ma T, Tang J, Zhao J.

Cancer Treat Rev. 2015 Jun;41(6):554-67. doi: 10.1016/j.ctrv.2015.04.005. Epub 2015 Apr 11. Review.

PMID:
25890842
20.

Statin use and cancer risk: a comprehensive review.

Boudreau DM, Yu O, Johnson J.

Expert Opin Drug Saf. 2010 Jul;9(4):603-21. doi: 10.1517/14740331003662620. Review.

Supplemental Content

Support Center